ALDH2 and neoplasm: The CPTAC prediction through the UALCAN platform showed markedly lower ALDH2 protein levels in tumorous (n = 108) than those in normal tissues (n = 71, P = 2.04×10-41) (Fig. 3A), and the trend continued regardless of the tumor grade (Fig. 3B).